Results 251 to 260 of about 9,166,726 (386)

RT-QuIC detection of chronic wasting disease prions in third eyelids from white-tailed deer

open access: gold
Jennifer Høy‐Petersen   +7 more
openalex   +1 more source

Bedside Assessment of Downgaze Limit by Amplitude

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Bedside assessment of downgaze palsy could be difficult, due to the lack of a marker to differentiate normal from palsy, which could delay the diagnosis of progressive supranuclear palsy (PSP). Amplitude based bedside assessment using the intercanthal line as a marker was reported to easily identify, quantify, and record downgaze ...
Tao Xie   +6 more
wiley   +1 more source

Inflammatory eyelid diseases in children. Рart I.

open access: bronze
Л. А. Ковалева   +4 more
openalex   +1 more source

Efficacy and Safety of IncobotulinumtoxinA for Treatment of Sialorrhea: A Multicenter, Phase 3 Study in Japan

open access: yesMovement Disorders Clinical Practice, EarlyView.
This study demonstrated significant treatment efficacy and safety of incobotulinumtoxinA injection in Japanese patients with chronic sialorrhea caused by Parkinson's disease and other neurological conditions. Suppression of salivary secretion and improvement in drooling symptoms were also observed throughout 48 weeks.
Nobutaka Hattori   +15 more
wiley   +1 more source

Disease‐Modifying Trials in Treated Parkinson's Disease: “Stable Treated” Does Not Equate with Biological Stability

open access: yesMovement Disorders, EarlyView.
Abstract Traditionally, clinical trials of putative disease‐modifying therapies in Parkinson's disease have enrolled untreated patients at the earliest clinical stages of their disease. Due to a number of challenges inherent with this approach, there has been a recent move to a different study design, enrolling patients who are already taking “stable ...
M. Maral Mouradian   +2 more
wiley   +1 more source

Pregnenolone Reduces L‐Dopa‐Induced Dyskinesias in Female Parkinsonian Monkeys

open access: yesMovement Disorders, EarlyView.
Pregnenolone is the first neurosteroid synthesized from cholesterol in the brain. Ovariectomized female monkeys were tested as a model of women in menopause. They were lesioned with MPTP modeling Parkinson's disease and treated with levodopa (L‐dopa) to induce dyskinesias.
Mélanie Bourque   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy